Category Archives: People

Vamorolone Demonstrates On-Target Glucocorticoid Activity Without the Immunosuppression Characteristic of Traditional Corticosteroids at Clinical Doses

Data Demonstrate Vamorolone’s Balanced Corticosteroid Profile with On-Target Glucocorticoid Activity and Without Evidence of Significant Immunosuppressive Activity at Clinical Doses CORAL GABLES, Fla., June 30, 2026 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-treat diseases, […]

ALX Oncology Appoints Scott Garland as Chairman of the Board and Michael Listgarten as General Counsel

Strengthens Leadership with Veteran Executives with Decades of Industry Experience Scott Garland Succeeds Co-Founder Corey Goodman, Ph.D., After More Than a Decade of Foundational Leadership SOUTH SAN FRANCISCO, Calif., June 30, 2026 (GLOBE NEWSWIRE) — ALX Oncology Holdings Inc. (“ALX Oncology,” Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to […]

Quince Therapeutics Appoints Recognized Leaders in Pulmonary Medicine to Scientific Advisory Board

SOUTH SAN FRANCISCO, Calif., June 30, 2026 (GLOBE NEWSWIRE) — Quince Therapeutics, Inc. (Nasdaq: QNCX), a clinical stage biopharmaceutical company focused on the development of novel, disease modifying therapies for serious underserved diseases, today announced the formation of a Scientific Advisory Board (SAB) of leading clinicians to support the advancement of LAM-001, an inhaled formulation […]

Weight Watchers Med+ Establishes Access to GLP-1s Through Medicare GLP-1 Bridge Program

Weight Watchers expands access for Med+ Medicare beneficiaries to GLP-1 medications covered by the Medicare Bridge Program. NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) — WW International, Inc. (NASDAQ: WW) (“Weight Watchers”), the global leader in science-backed weight health, today announced that Weight Watchers Med+ will support Medicare members seeking access to GLP-1 medications under […]

FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.3% for the Treatment of Plaque Psoriasis in Children as Young as Age 2

ZORYVE cream 0.3% is the first once-daily, non-steroidal therapy approved for children with plaque psoriasis as young as 2 years of age ZORYVE cream 0.3% is safe, effective, and well-tolerated for use anywhere on the body with no restrictions on duration of use Seventh FDA approval for ZORYVE in four years WESTLAKE VILLAGE, Calif., June […]

Twentyeight Health partners with Clue to expand access to affordable birth control nationwide

Bridging the gap between daily cycle tracking and provider-led contraceptive care for personalized reproductive health NEW YORK, June 29, 2026 (GLOBE NEWSWIRE) — Twentyeight Health, the leading women’s telehealth platform, today announced a partnership with Clue, the science-backed menstrual and reproductive health app trusted by millions worldwide. Through this partnership, US-based Clue users can seamlessly access […]

PetVivo Reports Financial and Operational Results for Fiscal 2026

MINNEAPOLIS, MN, US, June 29, 2026 (GLOBE NEWSWIRE) — PetVivo Holdings, Inc. (OTCQX: PETV) (OTCID: PETVW), in cooperation with its wholly-owned subsidiaries, Cosmeta Corp, PetVivo Animal Health, Inc. and PetVivo AI, Inc., a leading provider of medical devices and biomedical therapeutics for equines and companion animals, reported operational results for the fourth quarter of its […]

Zoumalan, MD FACS Inc. Announces Its Natural Looking Blepharoplasty® Approach as Demand Grows for Natural Eyelid Surgery Results

Board-certified ophthalmologist and ASOPRS fellowship-trained surgeon Dr. Christopher I. Zoumalan, MD, FACS, explains how his trademarked Natural Looking Blepharoplasty® reflects the 2026 “less-is-more” movement in facial aesthetics. Beverly Hills, CA, June 29, 2026 (GLOBE NEWSWIRE) — Zoumalan, MD FACS Inc. today announced its trademarked Natural Looking Blepharoplasty® approach to eyelid rejuvenation as growing demand for […]

Tilray Brands Strengthens Global Medical Cannabis Platform and Canadian Patient Access Through HelloMD Acquisition

Acquisition Will Expand Patient Access, Strengthen Digital Healthcare Capabilities, and Create a Fully Vertically Integrated Medical Cannabis Framework for Tilray in Canada NEW YORK and TORONTO, June 29, 2026 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY) (“Tilray”), a global leader in medical cannabis, today announced the acquisition of HelloMD Corporation, a digital […]

Voyager’s Tau-Targeted Gene Therapy VY1706 for Alzheimer’s Disease to Be Featured in Developing Topics Poster Presentation at AAIC 2026

LEXINGTON, Mass., June 29, 2026 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging genetics to treat neurological diseases, today announced a Developing Topics (late-breaking) poster presentation at the upcoming Alzheimer’s Association International Conference (AAIC) taking place in London, July 12-15, 2026. The Developing Topics poster presentation will feature VY1706, […]